Log in to save to my catalogue

Ramucirumab for the treatment of patients with gastric or gastroesophageal junction cancer in commun...

Ramucirumab for the treatment of patients with gastric or gastroesophageal junction cancer in commun...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1994367551

Ramucirumab for the treatment of patients with gastric or gastroesophageal junction cancer in community oncology practices

About this item

Full title

Ramucirumab for the treatment of patients with gastric or gastroesophageal junction cancer in community oncology practices

Publisher

Tokyo: Springer Japan

Journal title

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2018-09, Vol.21 (5), p.831-844

Language

English

Formats

Publication information

Publisher

Tokyo: Springer Japan

More information

Scope and Contents

Contents

Background
Limited real-world research has investigated ramucirumab for the treatment of patients with gastric or gastroesophageal junction (GEJ) cancer. This study was designed to describe ramucirumab monotherapy or combination therapy use in a community oncology practice setting.
Methods
This was a retrospective observational cohort stud...

Alternative Titles

Full title

Ramucirumab for the treatment of patients with gastric or gastroesophageal junction cancer in community oncology practices

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1994367551

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1994367551

Other Identifiers

ISSN

1436-3291

E-ISSN

1436-3305

DOI

10.1007/s10120-018-0796-z

How to access this item